In epidemiology, statistical power determines whether a study can accurately detect an effect of a given size with a specified probability, typically 80% or higher. When studies fall below that threshold, the consequences extend well beyond inconclusive results.
Underpowered studies distort effect estimates, reduce the reliability of published findings and introduce avoidable bias into the evidence base. For teams working in real-world data (RWD) and real-world evidence (RWE), this has direct implications for regulatory decisions, safety monitoring and commercial strategy.
False negatives: failure to detect true effects
Low statistical power increases the probability of a Type II error, where a study fails to reject a null hypothesis when a true, significant effect exists.
In practice, this means:
- True associations between exposures and outcomes are missed
- Treatment effects appear null despite clinically meaningful benefits
- Safety signals remain undetected
- Meaningful disease predictors go unobserved
This is not a neutral outcome and when evidence is interpreted as "no effect," underpowered studies can result in delayed intervention, misinform clinical guidance and bias downstream meta-analyses.
Effect size inflation and the winner’s curse
When underpowered studies produce statistically significant findings, the observed effect sizes are often overestimated. This pattern is commonly referred to as the winner’s curse.
In small samples, only large observed effects tend to reach conventional significance thresholds, such as p < 0.05. These estimates are more likely to reflect random variation or noise rather than the true underlying effect.
As a result, reported effect sizes may be systematically overestimated, while subsequent, well-powered studies often produce attenuated estimates. Over time, this can create apparent inconsistencies across the literature, contributing to replication failure and weakening confidence in early evidence.
Low positive predictive value and false discoveries
Statistical significance does not guarantee that a finding is true. In low-power settings, the positive predictive value (PPV) of a significant result declines.
PPV depends on statistical power, the Type I error rate and the prior probability of a true effect. When power is low, even a nominal alpha of 0.05 yields a higher proportion of false positives among significant findings.
Contributing factors include:
- Random error amplified by small sample size
- Residual confounding
- Model instability and overfitting
The result is a body of literature with a higher signal-to-noise ratio, where spurious associations are more likely to be published and pursued.
Ethical implications in human research
Clinical and population health studies rely on participant contribution under an implicit expectation that the research will generate scientific value.
Underpowered designs raise ethical concerns when participants are exposed to risk without a reasonable probability of producing informative results. They also limit the study’s ability to answer the research question it poses and divert resources from studies with stronger design rigor. For this reason, institutional review boards and funding bodies increasingly evaluate statistical power as a core component of ethical study design.
Resource inefficiency and cumulative bias
Underpowered studies consume time, funding and data infrastructure while contributing limited reliable evidence.
More importantly, they introduce bias into the cumulative evidence base:
- Meta-analyses may incorporate inflated or null-biased estimates
- Research agendas shift toward non-reproducible findings
- Decision-making relies on unstable evidence
In aggregate, this slows scientific progress and increases the cost of generating reliable real-world evidence.
Why this matters for real-world data research
Real-world data studies often involve complex cohorts, heterogeneous populations and observational designs that are already susceptible to bias. Insufficient power compounds these challenges by making it harder to distinguish meaningful effects from random variation. These issues become especially visible when cohort definitions are overly restrictive, rare outcomes are evaluated without adequate follow-up or subgroup analyses are conducted without sufficient events per variable. In each case, the study may appear analytically sound while lacking the statistical foundation needed to produce stable, interpretable results.
Designing real-world data studies with adequate power requires careful alignment between the research question, appropriate patient controls, outcome incidence and available data. Researchers need to understand whether the dataset can support the intended analysis before results are generated. This includes pressure-testing cohort definitions, expected event counts and follow-up windows against the realities of the available data. That planning helps ensure the study can produce evidence that is fit for decision-making.
The bottom line
Underpowered studies introduce systematic error into effect estimation and interpretation, raising the risk of misleading conclusions. For epidemiology and RWE teams, sufficient statistical power is essential for valid inference, reproducibility and ethical research that supports reliable scientific and clinical decision-making.
